CBX3, chromobox 3, 11335

N. diseases: 53; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0376544
Disease: Hematopoietic Neoplasms
Hematopoietic Neoplasms
0.010 Biomarker group BEFREE Our findings demonstrate that treatment with AZA, which affects an epigenetic reader protein and targets HP1γ, or a bromodomain inhibitor is a novel strategy that can be used to treat patients with hematopoietic neoplasms with AZA resistance. 30386240 2018